The delegation of the Enterprise Singapore Team visited NCC Japan.

On May 27, 2025.

The delegation of the Enterprise Singapore team led by Dr Clarice Chen, Director of Healthcare and Biomedical, visited NCC Japan. Enterprise Singapore is a statutory board under the Ministry of Trade and Industry of the Singapore Government. It aims to develop Singapore into a global hub for trade and startups and support enterprises in capability building, innovation, and globalization. In the healthcare sector, it is actively involved in the development of precision medicine (a customized approach to disease prevention and treatment), while supporting a variety of startups, including digital health technologies, wearable sensors, and AI-based devices.

To explore a potential collaboration, the Enterprise Singapore kindly shared their vision and activities, while  NCC Japan presented our commitment on Cancer Genomic Medicine in Japan. That included the role of Center for Cancer Genomics and Advanced Therapeutics (C-CAT), and clinical research initiatives leveraging C-CAT data. NCC Japan’s new initiative to introduce oversea biotech companies to development and business opportunities in Japan was also discussed.

It was agreed that both parties would continue to exchange information and explore opportunities for potential collaboration.

Participants from Enterprise Singapore:

• Clarice CHEN/Director, Healthcare and Biomedical 
• Sock Yue THONG/Deputy Director, Precision Medicine and Medtech 
• Jake CHING/Development Partner, Precision Medicine and Medtech 
• Amanda Dizon/Regional Director, North Asia and Oceania 
• Nozomi SEKI/Senior Business Development Manager, North Asia 

Participants from NCC Japan:

• Yayoi ANDO/Section Head, Clinical Trial Management Section, Research Management Division, Clinical Research Support Office/ Department of Hematology, NCCH
• Takashi YUGAWA/Chief, Section of Data Science Strategy, C-CAT
• Yusuke OKUMA/Chief, Section of Liaison for Cancer Genomic Medicine Hospitals, C-CAT
• Wakako TOGA/Deputy Director(international), Strategic Planning Bureau